Evidence map›Paper›PMID 36528697›Full record

ArticleAnnals of nuclear medicine2023

Prognostic value of semi-quantitative parameters of

Baoyu Wan, Song Zhang, Peng Wang, Pengyi Deng, Wenli Dai

Abstract read
In one paragraph

Article in Annals of nuclear medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The [European journal of nuclear medicine and molecular imaging · 2026
    Pooled it
  2. Predictive values of baselineBone marrow transplantation · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Baoyu WanDepartment of Nuclear Medicine, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, China.ORCID https://orcid.org/0000-0002-2482-7518
Song ZhangDepartment of Nuclear Medicine, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, China.
Peng WangDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443000, Hubei, China.
Pengyi DengDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443000, Hubei, China. dpy@ctgu.edu.cn.
Wenli DaiDepartment of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443000, Hubei, China. daiwenli@ctgu.edu.cn.

Funding

Natural Science Foundation of Hubei Province 2018CFB147Yichang Medical and Health Research Project No. A20-2-005
6 · The paper itself

Abstract

objectiveTo investigate the prognostic value of fluroine-18 fluorodexyglucose positron emission tomography/computed tomography (

methodsA total of 38 NDMM patients who underwent

resultsUnivariate analysis showed that aMTV ≥ 90.97cm

conclusionaMTV can predict PFS and OS of NDMM patients better than other parameters. NS which combined with aMTV can predict OS of NDMM patients better and can provide an accurate and simple method for risk stratification of NDMM patients.

Indexed as

Multiple MyelomaPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansPrognosisRadiopharmaceuticalsRetrospective StudiesTumor BurdenFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTaMTVaTLGNewly diagnosed multiple myelomaPrognosis

Identifiers

PMID36528697
PMCPMC9943948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.